Rights Mar 16, 2016 Mar 17, 2016 May 12, 2015 Rights ratio: 5 share for every 116 held at a price of Rs 245.0 Rights Aug 23, 2012-Jul 14, 2011 Rights ratio: 1 share for every 7 held at a price of Rs ...

Sun Pharma stated that it has entered into an agreement with Zaza Industrial Holdings K.K., Japan, to sell 100% of its shares in Sun Pharma Japan Technical Operations, a step-down subsidiary.

Drugmaker Sun Pharmaceutical Industries has inked an agreement with Zaza Industrial Holdings KK (Japan) to sell 100 per cent shares in its step-down subsidiary Sun Pharma Japan Technical ...

ICICI Pru Regular Savings Fund - Direct (IDCW-Q) 36.83 2,03,104 1.16 ICICI Pru Regular Savings Fund (IDCW-Q) 36.83 2,03,104 1.16 ICICI Pru Regular Savings Fund (IDCW ...

Sun Pharma Advanced Research Company Ltd. (SPARC) is a clinical stage bio-pharmaceutical company engaged in creating new drugs and delivery systems. The Company works on innovation and new product ...

Companies that have grown profits and net profit margins over the past 12 months ...

HSBC has identified its top picks in the Indian pharmaceutical sector, maintaining a "buy" rating on Cipla Ltd., Sun Pharmaceutical Industries Ltd., Lupin Ltd., Torrent Pharmaceuticals Ltd., and ...

Sun Pharmaceutical Industries or Sun Pharma is India’s leading pharmaceutical firm which is known for the production of Active Pharmaceutical Ingredients (APIs). The company is headquartered in ...

Stocks picks for 2025: M&M, Sun Pharma, and Dalmia Bharat are the top three stock picks by Sumeet Bagadia of Choice Broking for the new year with significant potential for long-term-based returns.( ...

A US district court has granted an injunction sought by Incyte on the launch of Sun Pharma's recently approved Leqselvi for alopecia areata. In a brief filing with the National Stock Exchange (NSE ...

Sun Pharma will take up the amalgamation of five wholly-owned subsidiaries at an equity shareholder meet next month, the company said. The subsidiaries are being amalgamated as part of ongoing ...